Veradigm Inc. (NASDAQ:MDRX – Get Free Report) shares saw unusually-high trading volume on Monday. 498,926 shares traded hands during trading, an increase of 321% from the previous session’s volume of 118,634 shares. The stock last traded at $4.80 and had previously closed at $4.95.
Veradigm Stock Down 4.0%
The company has a market capitalization of $580.92 million, a price-to-earnings ratio of 23.25 and a beta of 0.51. The stock has a 50 day simple moving average of $4.89 and a 200 day simple moving average of $4.82.
Veradigm Company Profile
Veradigm Inc (NASDAQ:MDRX), formerly known as Allscripts Healthcare Solutions, is a healthcare technology company that provides software, data and connectivity solutions for healthcare organizations, physicians, patients, payers and life sciences companies. The company changed its name to Veradigm in 2023 to reflect its broader focus on using healthcare data to support clinical, operational and commercial decision-making.
Veradigm’s offerings include electronic health record and practice-management solutions, electronic prescribing, revenue-cycle and financial management tools, patient engagement services and healthcare information-exchange capabilities.
Further Reading
- Five stocks we like better than Veradigm
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
- Buy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big Catalysts
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
